{"nbformat": 4, "nbformat_minor": 5, "cells": [{"cell_type": "markdown", "metadata": {}, "source": "### ETNA-VTE Data Analysis\nThis notebook analyzes the data from the ETNA-VTE study to visualize trends in recurrent VTE and major bleeding events."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "import pandas as pd\nimport matplotlib.pyplot as plt\n\n# Sample data from ETNA-VTE study\ndata = {'Event': ['Recurrent VTE', 'Major Bleeding'], 'Annualized Rate (%)': [2.7, 1.5]}\ndf = pd.DataFrame(data)\n\n# Plotting the data\nplt.bar(df['Event'], df['Annualized Rate (%)'], color=['blue', 'orange'])\nplt.title('Annualized Rates of Recurrent VTE and Major Bleeding')\nplt.ylabel('Annualized Rate (%)')\nplt.show()"}, {"cell_type": "markdown", "metadata": {}, "source": "### Discussion\nThis analysis provides insights into the effectiveness and safety of edoxaban in treating VTE, highlighting the importance of continuous monitoring."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "# Further analysis can be added here."}, {"cell_type": "markdown", "metadata": {}, "source": "\n\n\n\n***\n### [**Evolve This Code**](https://biologpt.com/?q=Evolve%20Code%3A%20This%20code%20analyzes%20patient%20data%20from%20the%20ETNA-VTE%20study%20to%20identify%20trends%20in%20recurrent%20VTE%20and%20bleeding%20events%20over%20time.%0A%0AInclude%20more%20detailed%20patient%20demographics%20and%20treatment%20history%20to%20enhance%20the%20analysis.%0A%0AEdoxaban%20treatment%20Venous%20Thromboembolism%20ETNA-VTE%20Europe%2018%20months%20review%0A%0A%23%23%23%20ETNA-VTE%20Data%20Analysis%0AThis%20notebook%20analyzes%20the%20data%20from%20the%20ETNA-VTE%20study%20to%20visualize%20trends%20in%20recurrent%20VTE%20and%20major%20bleeding%20events.%0A%0Aimport%20pandas%20as%20pd%0Aimport%20matplotlib.pyplot%20as%20plt%0A%0A%23%20Sample%20data%20from%20ETNA-VTE%20study%0Adata%20%3D%20%7B%27Event%27%3A%20%5B%27Recurrent%20VTE%27%2C%20%27Major%20Bleeding%27%5D%2C%20%27Annualized%20Rate%20%28%25%29%27%3A%20%5B2.7%2C%201.5%5D%7D%0Adf%20%3D%20pd.DataFrame%28data%29%0A%0A%23%20Plotting%20the%20data%0Aplt.bar%28df%5B%27Event%27%5D%2C%20df%5B%27Annualized%20Rate%20%28%25%29%27%5D%2C%20color%3D%5B%27blue%27%2C%20%27orange%27%5D%29%0Aplt.title%28%27Annualized%20Rates%20of%20Recurrent%20VTE%20and%20Major%20Bleeding%27%29%0Aplt.ylabel%28%27Annualized%20Rate%20%28%25%29%27%29%0Aplt.show%28%29%0A%0A%23%23%23%20Discussion%0AThis%20analysis%20provides%20insights%20into%20the%20effectiveness%20and%20safety%20of%20edoxaban%20in%20treating%20VTE%2C%20highlighting%20the%20importance%20of%20continuous%20monitoring.%0A%0A%23%20Further%20analysis%20can%20be%20added%20here.%0A%0A)\n***\n\n### [Created with BioloGPT](https://biologpt.com/?q=Paper%20Review%3A%20Treatment%20of%20Venous%20Thromboembolism%20with%20Edoxaban%20over%2018%20Months%3A%20Results%20from%20ETNA-VTE%20Europe)\n[![BioloGPT Logo](https://biologpt.com/static/icons/bioinformatics_wizard.png)](https://biologpt.com/)\n***"}], "metadata": {"title": "This code analyzes patient data from the ETNA-VTE study to identify trends in recurrent VTE and bleeding events over time.", "kernelspec": {"display_name": "Python 3", "language": "python", "name": "python3"}, "language_info": {"name": "python", "version": "3.13", "mimetype": "text/x-python", "codemirror_mode": {"name": "ipython", "version": 3}, "file_extension": ".py", "pygments_lexer": "ipython3"}, "author": "BioloGPT", "creation_date": "2025-01-29", "tags": ["Edoxaban VTE treatment results", "biology", "bioinformatics"]}}